UAB “Vittamed”, a developer of unique technologies for monitoring ultrasonic brain physiological parameters and a producer of diagnostic equipment, has set up in Kaunas Science and Technology Park located in the Santaka Valley.
The company focuses on developing high tech products and exporting them. At present, its unique neurodiagnostic technologies have no competitors in the world. This is a huge advantage and a serious challenge as well which require much effort to create a market as well as investment in order to open new market niches which are not in existence as yet. Vittamed Corporation, the parent company of the afore-mentioned company which operates in Boston (USA), has attracted an investment worth USD 10 million recently which gives a significant impulse to achieve the objectives set.
According the KTU prof. Arminas Ragauskas, an inventor and developer of technologies, clinical data held by the best neuron research centres, joint R&D projects funded by the European Commission, NASA and scientific articles published in prestigious US and EU scientific journals give a good starting point for the commercialisation of technologies.
“It is sought to develop the innovative ultrasonic technologies created and designed to measure absolute values of human intracranial pressure in a non-invasive manner and carry out the monitoring the self-regulation of brain circulation in real time into neurodiagnostic products capable of transforming the established standards of clinical neurodiagnostics worldwide”, – mentioned prof. A. Ragauskas.
At present, UAB “Vittamed”, led by CEO Edvardas Satkauskas, is developing its first commercial product, i.e. a non-invasive intracranial pressure meter, and is preparing to enter the European and US markets. The company has extensive experience in developing new technologies, launching, implementing and managing international R&D projects and cooperates with educational institutions, hospitals, state authorities and business organisations across the entire world. The company collaborates and constantly seeks contact with companies developing ultrasonic technologies and IT solutions in the medical field.